Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP557795.RADEnCoP3Oo0_a3UF12skOEMBhtIDMaEQrhsd2h70osUY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP557795.RADEnCoP3Oo0_a3UF12skOEMBhtIDMaEQrhsd2h70osUY130_assertion type Assertion NP557795.RADEnCoP3Oo0_a3UF12skOEMBhtIDMaEQrhsd2h70osUY130_head.
- NP557795.RADEnCoP3Oo0_a3UF12skOEMBhtIDMaEQrhsd2h70osUY130_assertion wasGeneratedBy ECO_0000203 NP557795.RADEnCoP3Oo0_a3UF12skOEMBhtIDMaEQrhsd2h70osUY130_provenance.
- NP557795.RADEnCoP3Oo0_a3UF12skOEMBhtIDMaEQrhsd2h70osUY130_assertion wasDerivedFrom befree-20150227 NP557795.RADEnCoP3Oo0_a3UF12skOEMBhtIDMaEQrhsd2h70osUY130_provenance.
- NP557795.RADEnCoP3Oo0_a3UF12skOEMBhtIDMaEQrhsd2h70osUY130_assertion SIO_000772 19118062 NP557795.RADEnCoP3Oo0_a3UF12skOEMBhtIDMaEQrhsd2h70osUY130_provenance.
- NP557795.RADEnCoP3Oo0_a3UF12skOEMBhtIDMaEQrhsd2h70osUY130_assertion evidence source_evidence_literature NP557795.RADEnCoP3Oo0_a3UF12skOEMBhtIDMaEQrhsd2h70osUY130_provenance.
- NP557795.RADEnCoP3Oo0_a3UF12skOEMBhtIDMaEQrhsd2h70osUY130_assertion description "[Patients with newly diagnosed oligodendroglioma or oligoastrocytoma with a MIB-1 index of >5% or recurrent low-grade gliomas received temozolomide (75 mg/m(2)/day in 11-week cycles of 7 weeks on/4 weeks off).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP557795.RADEnCoP3Oo0_a3UF12skOEMBhtIDMaEQrhsd2h70osUY130_provenance.